These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 399187)

  • 1. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
    Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
    Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
    Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic beta cell function in offspring of conjugal diabetic parents. Assessment by IRI and C-peptide ratio.
    Snehalatha C; Mohan V; Ramachandran A; Jayashree R; Viswanathan M
    Horm Metab Res; 1984 Dec; 16 Suppl 1():142-4. PubMed ID: 6398253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
    Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise increase in plasma insulin and C-peptide concentrations in obese, in obese hypertensive, and in obese hypertensive diabetic subjects.
    Donatelli M; Scarpinato A; Bucalo ML; Russo V; Iraci T; Vassallo G
    Diabetes Res; 1991 Jul; 17(3):125-9. PubMed ID: 1841027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
    J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum prolactin in obese subjects with glucose intolerance before and after treatment with phenformin].
    Pata P; Smedile G; Morabito S; Mancuso TR; Arcoraci A
    Boll Soc Ital Biol Sper; 1981 Mar; 57(5):522-5. PubMed ID: 7020721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic extraction of insulin in non-insulin dependent diabetes. Comparative study of obese and non-obese patients.
    Snehalatha C; Mohan V; Ramachandran A; Jayashree R; Viswanathan M
    Diabete Metab; 1984 Sep; 10(3):175-80. PubMed ID: 6386556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, immunoreactive insulin and C-peptide immunoreactivity in patients with acute viral hepatitis.
    Scremin S; Caprioglio L; D'Aquino M; Virgili F; Fabbro A; Okolicsanyi L
    Horm Metab Res; 1983 Jul; 15(7):313-6. PubMed ID: 6350137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin metabolism in hypothalamic obesity.
    Blatniczky L; Kautzky L; Péter F
    Exp Clin Endocrinol; 1990 Sep; 96(1):83-9. PubMed ID: 2279530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increase of circulating levels of insulin and C-peptide: common factors in essential hypertension and overweight].
    Sechi LA; Tedde R; Melis A; Pala A; Marigliano A; Orecchioni C; Pisanu G; Bartoli E
    Ann Ital Med Int; 1990; 5(4 Pt 1):348-52. PubMed ID: 2093360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
    Nakamori S; Ishikawa O; Ohigashi H; Sasakuma F; Shimizu T; Nakaizumi A; Furukawa H; Sasaki Y; Imaoka S
    Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children.
    Baldelli R; Bellone S; Castellino N; Petri A; Rapa A; Vivenza D; Bellone J; Broglio F; Ghigo E; Bona G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):255-9. PubMed ID: 16487433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between plasma insulin and C peptide and mild and severe obesity].
    García Pascual IJ; González Ruiz JM
    An Med Interna; 1993 Nov; 10(11):526-31. PubMed ID: 8117866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone effects on post-prandial glucose, insulin and C-peptide levels in obese subjects.
    De Marinis L; Mancini A; De Luca AM; Fiumara C; Zuppi P; Sammartano L; Valle D
    Diabetes Res; 1993; 23(2):83-91. PubMed ID: 7712683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin metabolism in obese children tested by oral and intravenous glucose loading].
    Blatniczky L; Halász Z
    Orv Hetil; 1989 Oct; 130(44):2357-61. PubMed ID: 2682447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc status in plasma of obese individuals during glucose administration.
    Chen MD; Lin PY; Sheu WH
    Biol Trace Elem Res; 1997; 60(1-2):123-9. PubMed ID: 9404681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.